Sabby Management’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-53,648
Closed -$497K 56
2024
Q2
$497K Sell
53,648
-39,122
-42% -$434K 0.33% 10
2024
Q1
$1.23M Buy
+92,770
New +$1.65M 0.71% 8
2023
Q4
Sell
-25,400
Closed -$324K 80
2023
Q3
$324K Buy
+25,400
New +$664K 0.24% 24
2023
Q1
Sell
-7,450
Closed -$1.05M 120
2022
Q4
$1.05M Buy
+7,450
New +$3.23M 0.92% 15
2021
Q3
Sell
-340
Closed -$2.34M 198
2021
Q2
$2.34M Sell
340
-291
-46% -$2.01M 0.33% 45
2021
Q1
$4.62M Buy
+631
New +$5.29M 0.9% 20
2018
Q1
Sell
-21
Closed -$110K 176
2017
Q4
$110K Buy
+21
New +$141K 0.01% 132
2017
Q2
Sell
-108
Closed -$1.04M 253
2017
Q1
$1.04M Sell
108
-84
-44% -$839K 0.06% 129
2016
Q4
$2.01M Buy
192
+128
+200% +$1.53M 0.12% 103
2016
Q3
$888K Sell
64
-84
-57% -$1.17M 0.03% 194
2016
Q2
$1.61M Sell
148
-9
-6% -$104K 0.08% 120
2016
Q1
$1.92M Sell
157
-3
-2% -$31.4K 0.1% 102
2015
Q4
$2.06M Sell
160
-14
-8% -$174K 0.11% 120
2015
Q3
$2.24M Buy
+174
New +$2.58M 0.09% 144
2015
Q2
Sell
-108
Closed -$1.57M 354
2015
Q1
$1.57M Buy
+108
New +$1.54M 0.07% 162

Other funds holding RDHL

Sabby Management's RDHL Position: Q3 2024 in Review

Sabby Management sold out of Redhill Biopharma (RDHL) in Q3 2024, closing a stake of 53,648 shares — an estimated $497K sold.

Sabby Management first reported a position in RDHL in Q1 2015 and held it in 15 quarters. The position peaked at $4.62M in Q1 2021. 11 funds tracked by Wall St. Rank hold RDHL as of Q3 2024.

  • Sabby Management reported no remaining Redhill Biopharma position as of Q3 2024 after selling out during the quarter.
  • Sabby Management sold 53,648 Redhill Biopharma shares in Q3 2024, an estimated $497K.
  • Sabby Management first reported a position in Redhill Biopharma in Q1 2015 and held it in 15 quarters.
  • Sabby Management's Redhill Biopharma position peaked at $4.62M in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2024.

Based on Sabby Management's 13F filing for Q3 2024, filed 14 Nov 2024.